298 related articles for article (PubMed ID: 16807695)
1. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
Xu X; Wei H; Dong Z; Chen Y; Tian Z
Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
[TBL] [Abstract][Full Text] [Related]
2. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
[TBL] [Abstract][Full Text] [Related]
3. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice.
Huang W; Dong Z; Wei H; Ding C; Sun R; Tian Z
Liver Int; 2006 Apr; 26(3):339-45. PubMed ID: 16584397
[TBL] [Abstract][Full Text] [Related]
4. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
Wang J; Sun R; Wei H; Dong Z; Tian Z
Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
[TBL] [Abstract][Full Text] [Related]
5. Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB.
Imose M; Nagaki M; Kimura K; Takai S; Imao M; Naiki T; Osawa Y; Asano T; Hayashi H; Moriwaki H
Hepatology; 2004 Nov; 40(5):1160-9. PubMed ID: 15455409
[TBL] [Abstract][Full Text] [Related]
6. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver.
Miyagi T; Takehara T; Tatsumi T; Suzuki T; Jinushi M; Kanazawa Y; Hiramatsu N; Kanto T; Tsuji S; Hori M; Hayashi N
Hepatology; 2004 Nov; 40(5):1190-6. PubMed ID: 15486936
[TBL] [Abstract][Full Text] [Related]
7. Dregea volubilis ameliorates concanavalin A-induced liver injury by facilitating apoptosis of activated T cells.
Gong F; Shen Y; Zhang C; Xu J; Wu X; Hua Z; Xu Q
Exp Biol Med (Maywood); 2008 Sep; 233(9):1124-32. PubMed ID: 18535162
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments.
Miura N; Yamamoto M; Fukutake M; Ohtake N; Iizuka S; Ishige A; Sasaki H; Fukuda K; Yamamoto T; Hayakawa S
Int Immunol; 2005 May; 17(5):513-22. PubMed ID: 15778290
[TBL] [Abstract][Full Text] [Related]
9. Critical contribution of liver natural killer T cells to a murine model of hepatitis.
Takeda K; Hayakawa Y; Van Kaer L; Matsuda H; Yagita H; Okumura K
Proc Natl Acad Sci U S A; 2000 May; 97(10):5498-503. PubMed ID: 10792025
[TBL] [Abstract][Full Text] [Related]
10. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes.
Tagawa Y; Sekikawa K; Iwakura Y
J Immunol; 1997 Aug; 159(3):1418-28. PubMed ID: 9233639
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-- mediated immune hepatic injury.
Tsai CC; Huang WC; Chen CL; Hsieh CY; Lin YS; Chen SH; Yang KC; Lin CF
J Immunol; 2011 Oct; 187(7):3867-77. PubMed ID: 21873526
[TBL] [Abstract][Full Text] [Related]
12. Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury.
Nakajima H; Takagi H; Horiguchi N; Toyoda M; Kanda D; Otsuka T; Emoto Y; Emoto M; Mori M
Liver Int; 2006 Apr; 26(3):346-51. PubMed ID: 16584398
[TBL] [Abstract][Full Text] [Related]
13. RNA interference targeting Fas protects mice from fulminant hepatitis.
Song E; Lee SK; Wang J; Ince N; Ouyang N; Min J; Chen J; Shankar P; Lieberman J
Nat Med; 2003 Mar; 9(3):347-51. PubMed ID: 12579197
[TBL] [Abstract][Full Text] [Related]
14. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice.
Odashima M; Otaka M; Jin M; Horikawa Y; Matsuhashi T; Ohba R; Linden J; Watanabe S
Biochem Biophys Res Commun; 2006 Sep; 347(4):949-54. PubMed ID: 16859640
[TBL] [Abstract][Full Text] [Related]
15. Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF-alpha, IFN-gamma and glucocorticoids.
Fayad R; Sennello JA; Kim SH; Pini M; Dinarello CA; Fantuzzi G
Eur J Immunol; 2005 Aug; 35(8):2304-12. PubMed ID: 16047339
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
17. Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model.
Ito H; Hoshi M; Ohtaki H; Taguchi A; Ando K; Ishikawa T; Osawa Y; Hara A; Moriwaki H; Saito K; Seishima M
J Immunol; 2010 Oct; 185(8):4554-60. PubMed ID: 20844202
[TBL] [Abstract][Full Text] [Related]
18. Differential cytokine gene expression in CD4+ and CD8+ T cell subsets of calves.
Tanaka S; Aso H; Miyazawa K; Nagai Y; Watanabe K; Ohwada S; Kobayashi J; Yamaguchi T
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):84-91. PubMed ID: 17543393
[TBL] [Abstract][Full Text] [Related]
19. Effect of gamma radiation on cytokine expression and cytokine-receptor mediated STAT activation.
Han SK; Song JY; Yun YS; Yi SY
Int J Radiat Biol; 2006 Sep; 82(9):686-97. PubMed ID: 17032631
[TBL] [Abstract][Full Text] [Related]
20. Endogenous alpha-calcitonin gene-related peptide mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A.
Kamiyoshi A; Sakurai T; Ichikawa-Shindo Y; Iinuma N; Kawate H; Yoshizawa T; Koyama T; Muto S; Shindo T
Liver Int; 2009 May; 29(5):642-9. PubMed ID: 18673438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
